Next Article in Journal
Expanding the Use of PARP Inhibitors as Monotherapy and in Combination in Triple-Negative Breast Cancer
Next Article in Special Issue
A Comprehensive Analysis of the Thrombin Binding Aptamer Containing Functionalized Pyrrolo-2’-deoxycytidines
Previous Article in Journal
Strain-, Sex-, and Time-Dependent Antidepressant-like Effects of Cannabidiol
Previous Article in Special Issue
Aptamer Applications in Neuroscience
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 14
Issue 12
10.3390/ph14121271
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Pharmaceuticals 2021, 14(6), 554.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554

by
Zachary J. Tickner
1,* and
Michael Farzan
1,2
1
Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, FL 33458, USA
2
Emmune, Inc., Jupiter, FL 33458, USA
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2021, 14(12), 1271; https://doi.org/10.3390/ph14121271
Submission received: 8 September 2021 / Accepted: 5 November 2021 / Published: 6 December 2021
(This article belongs to the Special Issue Potential of the Aptamers to Fill Therapeutic and Diagnostic Gaps)
Versions Notes

Missing Citation

In the original article, Renzl, C.; Kakoti, A.; Mayer, G. Aptamer-Mediated Reversible Transactivation of Gene Expression by Light. Angew. Chem. Int. Ed. 2020, 59, 22414, doi:10.1002/anie.202009240 was not cited [1]. The citation has now been inserted in Section 2.8: Regulation of CRISPR-Cas Activity by Riboswitches, paragraph 2, and should read: A particularly interesting case was recently reported by Renzl et al., who incorporated aptamers to the photoreceptor PAL into gRNAs and demonstrated 546-fold regulation of mRNA levels in response to light in HeLa cells [190].

Reference

  1. Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Tickner, Z.J.; Farzan, M. Correction: Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554. Pharmaceuticals 2021, 14, 1271. https://doi.org/10.3390/ph14121271

AMA Style

Tickner ZJ, Farzan M. Correction: Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554. Pharmaceuticals. 2021; 14(12):1271. https://doi.org/10.3390/ph14121271

Chicago/Turabian Style

Tickner, Zachary J., and Michael Farzan. 2021. "Correction: Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554" Pharmaceuticals 14, no. 12: 1271. https://doi.org/10.3390/ph14121271

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop